Adults ages 18 to 70 who are living with active rheumatoid arthritis may qualify for a clinical research study evaluating an investigational oral medication.
Rheumatoid Arthritis Clinical Research Study
Age Range:
18 to 70
Gender:
Male and Female
Location:
New Port Richey
About the Study
Rheumatoid arthritis, or RA, is an autoimmune condition that can cause joint pain, swelling, stiffness, and inflammation. For some people, symptoms may continue even after trying available treatments.
This clinical research study evaluates an investigational oral medication called PTC844. Participants will be randomly assigned to receive either the investigational study medication or placebo once daily for 12 weeks, followed by a safety follow-up visit.
Qualifications
You may be able to join if you:
- Are 18 to 70 years of age
- Have been diagnosed with rheumatoid arthritis
- Have active rheumatoid arthritis with moderate disease activity or higher
- Are new to disease-modifying treatments for RA, have not responded well enough to certain RA treatments, or have been unable to tolerate disease-modifying antirheumatic drugs
- Are on no more than one permitted stable RA background therapy, if applicable
- Are willing and able to attend study visits and follow study procedures
Additional eligibility criteria will be reviewed by the study team.
Interested in Learning More?
Finding out if you qualify is easy and comes with no obligation.
See if you qualify.